William Blair & Company
FUSN

William Blair & Company’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

William Blair & Company’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-779,202
Closed -$16.6M – 1891
2024
Q1 		$16.6M Sell
779,202
-214,653
-22% -$2.57M 0.05% 241
2023
Q4 		$9.55M Buy
+993,855
New +$4.83M 0.03% 330

William Blair & Company's FUSN Position: Q2 2024 in Review

William Blair & Company sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 779,202 shares — an estimated $16.6M sold.

William Blair & Company first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $16.6M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • William Blair & Company reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • William Blair & Company sold 779,202 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $16.6M.
  • William Blair & Company first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
  • William Blair & Company's Fusion Pharmaceuticals Inc. Common Shares position peaked at $16.6M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on William Blair & Company's 13F filing for Q2 2024, filed 12 Aug 2024.